-Search query
-Search result
Showing 1 - 50 of 1,020 items for (author: li & wr)
EMDB-44965:
Sub-tomogram average of the RSV M lattice from native virions released from RSV-infected BEAS-2B cells cultured on EM grids
Method: subtomogram averaging / : Sibert BS, Wright ER
EMDB-44966:
Sub-tomogram average of a pair of RSV F trimers from native virions released from RSV-infected BEAS-2B cells cultured on EM grids
Method: subtomogram averaging / : Sibert BS, Wright ER
EMDB-44968:
Sub-tomogram average of two pairs of RSV F trimers from the surface of native virions released from RSV-infected BEAS-2B cells cultured on EM grids
Method: subtomogram averaging / : Sibert BS, Wright ER
EMDB-44969:
Sub-tomogram average of two pairs of RSV F trimers from the surface of native virions released from RSV-infected BEAS-2B cells cultured on EM grids
Method: subtomogram averaging / : Sibert BS, Wright ER
EMDB-44971:
Sub-tomogram average of two pairs of RSV F trimers from the surface of native virions released from RSV-infected BEAS-2B cells cultured on EM grids
Method: subtomogram averaging / : Sibert BS, Wright ER
EMDB-45639:
Cryo-EM structure of in-vitro alpha-synuclein fibril
Method: helical / : Sanchez JC, Borcik CG, Tonelli M, Sibert B, Rienstra CM, Wright ER, Cai K
PDB-9ck3:
Cryo-EM structure of in-vitro alpha-synuclein fibril
Method: helical / : Sanchez JC, Borcik CG, Tonelli M, Sibert B, Rienstra CM, Wright ER
EMDB-16917:
Human apo pseudouridine synthase 3 (PUS3)
Method: single particle / : Lin TY, Glatt S, Koziej L
EMDB-16926:
Human pseudouridine synthase 3 and tRNA-Gln
Method: single particle / : Lin TY, Glatt S
EMDB-19830:
Human pseudouridine synthase 3 (PUS3 R116A mutant) and two tRNA-Gln
Method: single particle / : Lin TY, Jezowski J, Glatt S
EMDB-19831:
Human pseudouridine synthase 3 (PUS3 R116A mutant) and one tRNA-Gln
Method: single particle / : Lin TY, Jezowski J, Glatt S
EMDB-19832:
Human pseudouridine synthase 3 (PUS3 D118A mutant) and two tRNA-Arg
Method: single particle / : Lin TY, Jezowski J, Glatt S
EMDB-19833:
Human pseudouridine synthase 3 (PUS3 D118A mutant) and two pre-tRNA-Arg
Method: single particle / : Lin TY, Jezowski J, Glatt S
EMDB-19834:
Human pseudouridine synthase 3 (PUS3 R116A mutant)
Method: single particle / : Lin TY, Glatt S
EMDB-19835:
Human pseudouridine synthase 3 (PUS3 K119A mutant)
Method: single particle / : Lin TY, Glatt S
EMDB-19836:
Human pseudouridine synthase 3 (wild type)
Method: single particle / : Lin TY, Glatt S
PDB-9enb:
Human pseudouridine synthase 3 (PUS3 R116A mutant) and two tRNA-Gln
Method: single particle / : Lin TY, Jezowski J, Glatt S
PDB-9enc:
Human pseudouridine synthase 3 (PUS3 R116A mutant) and one tRNA-Gln
Method: single particle / : Lin TY, Jezowski J, Glatt S
PDB-9ene:
Human pseudouridine synthase 3 (PUS3 D118A mutant) and two tRNA-Arg
Method: single particle / : Lin TY, Jezowski J, Glatt S
PDB-9enf:
Human pseudouridine synthase 3 (PUS3 D118A mutant) and two pre-tRNA-Arg
Method: single particle / : Lin TY, Jezowski J, Glatt S
PDB-9f9q:
Human apo pseudouridine synthase 3 (PUS3 D118A mutant)
Method: single particle / : Lin TY, Glatt S
EMDB-43296:
Constituent EM map: Focused refinement S100A1 of mouse RyR1 in complex with S100A1 (EGTA-only dataset)
Method: single particle / : Weninger G, Marks AR
EMDB-18051:
Inward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18052:
Inward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18054:
Inward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18055:
Outward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18057:
Outward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18059:
Outward-facing, slack proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
EMDB-18066:
Inward-facing, open2 proteoliposome complex I at 2.9 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18067:
Inward-facing, open1 proteoliposome complex I at 3.3 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18068:
Outward-facing, open2 proteoliposome complex I at 2.6 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18069:
Outward-facing, open1 proteoliposome complex I at 2.8 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18138:
Inward-facing, closed proteoliposome complex I at 2.7 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18139:
Inward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18140:
Inward-facing, open1 proteoliposome complex I at 2.9 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18141:
Outward-facing, closed proteoliposome complex I at 2.5 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18142:
Outward-facing, open2 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
EMDB-18143:
Outward-facing, open1 proteoliposome complex I at 2.6 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
PDB-8q0a:
Inward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
PDB-8q0f:
Inward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
PDB-8q0j:
Inward-facing, slack proteoliposome complex I at 3.8 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
PDB-8q0m:
Outward-facing, closed proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
PDB-8q0o:
Outward-facing, open2 proteoliposome complex I at 3.1 A. Initially purified in DDM.
Method: single particle / : Grba DN, Hirst J
PDB-8q0q:
Outward-facing, slack proteoliposome complex I at 3.6 A. Initially purified in DDM
Method: single particle / : Grba DN, Hirst J
PDB-8q1p:
Inward-facing, open2 proteoliposome complex I at 2.9 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
PDB-8q1u:
Inward-facing, open1 proteoliposome complex I at 3.3 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
PDB-8q1y:
Outward-facing, open2 proteoliposome complex I at 2.6 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
PDB-8q25:
Outward-facing, open1 proteoliposome complex I at 2.8 A, after deactivation treatment. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
PDB-8q45:
Inward-facing, closed proteoliposome complex I at 2.7 A. Initially purified in LMNG.
Method: single particle / : Grba DN, Hirst J
Pages: